Summary
Drugs in every major pharmacological category can impair both taste and smell function and do so more commonly than presently appreciated. Impairment usually affects sensory function at a molecular level, causing 2 major behavioural changes — loss of acuity (i.e. hypogeusia and hyposmia) and/or distortion of function (i.e. dysgeusia and dysosmia). These changes can impair appetite, food intake, cause significant lifestyle changes and may require discontinuation of drug administration.
Loss of acuity occurs primarily by drug inactivation of receptor function through inhibition of tastant/odorant receptor: (i) binding; (ii) Gs protein function; (iii) inositol trisphosphate function; (iv) channel (Ca++, Na++) activity; (v) other receptor inhibiting effects; or (vi) some combination of these effects. Distortions occur primarily by a drug inducing abnormal persistence of receptor activity (i.e. normal receptor inactivation does not occur) or through failure to activate: (i) various receptor kinases; (ii) Gi protein function; (iii) cytochrome P450 enzymes; or other effects which usually (iv) turn off receptor function; (v) inactivate tastant/odorant receptor binding; or (vi) some combination of these effects.
Termination of drug therapy is commonly associated with termination of taste/smell dysfunction, but occasionally effects persist and require specific therapy to alleviate symptoms. Treatment primarily requires restoration of normal sensory receptor growth, development and/or function. Treatment which restores sensory acuity requires correction of steps initiating receptor and other pathology and includes zinc, theophylline, magnesium and fluoride. Treatment which inhibits sensory distortions requires reactivation of biochemical inhibition at the receptor or inactivation of inappropriate stimulus receptor binding and/or correction of other steps initiating pathology including dopaminergic antagonists, γ-aminobutyric acid (GABA)-ergic agonists, calcium channel blockers and some orally active local anaesthetic, antiarrhythmic drugs.
Similar content being viewed by others
References
Brewster JL, de Valoir T, Dwyer ND, et al. An osmosensory signal transduction pathway in yeast. Science 1993; 259: 1760–3
Parkinson JS, Blair DF. Does E coli have a nose? Science 1993; 259: 1701–2
Maddock JR, Shapiro L. Polar localization of the chemoreceptor complex in the Escherichia coli cell. Science 1993; 259: 1717–29
Alley MRK, Maddock JR, Shapiro L. Requirement of the carboxyl terminus of a bacterial chemoreceptor for its targeted proleotysis. Science 1993; 259: 1754–7
Allen WF. Effects of various inhaled vapors on respiration and blood pressure in anesthetized, unanesthetized, sleeping and anosmic subjects. Am J Physiol 1929; 88: 620–32
Nisheno T, Sugiyano A, Tanaka A, et al. Effects of topical nasal anesthesia on shift of breathing route in adults. Lancet 1992; 339: 1497–9
The nose and the respiratory system [editorial]. Lancet 1992; 339: 1511–2
Kraus DH, Weir Jr CW, Yaeger Jr H, et al. Altered pulmonary function in patients with hyposmia. Clin Res 1986; 34: 579a
Henkin RI. Taste in man. In: Harrison D, Hinchcliffe R, editors. Scientific Foundations of Otolaryngology. London: Heinemann Medical Books, 1976: 468–83
Henkin RI. The definition of primary and accessory areas of olfaction as the basis for a classification of decreased olfactory acuity. In: Hayashi T, editor. Olfaction and Taste II. London: Pergamon Press, 1967: 235–52
Henkin RI. Evaluation and treatment of human olfactory dysfunction. In: English C, editor. Otolaryngology. Vol 2. Philadelphia: Lippincott, 1993: 1–86
Henkin RI. Allergic rhinitis. N Engl J Med 1992; 326: 576
Henkin RI. Salty and bitter taste. JAMA 1991; 265: 2253
Henkin RI. Disordered smell. Lancet 1988; 2: 901–2
Henkin RI. Concepts of therapy in taste and smell dysfunction: repair of sensory receptor function as primary treatment. In: Kurihara K, Suzuki N, Ogawa H, editors. Olfaction & Taste 11. Tokyo: Springer Verlag, 1994: 568–73
Henkin RI. Phantogeusia. In: Taylor RB, editor. Difficult Diagnosis II. Philadelphia: WB Saunders Co, 1992: 348–56
Henkin RI, Christiansen RL. Taste localization on the tongue, palate and pharynx of normal man. J Appl Physiol 1967; 22: 316–20
Henkin RI, Christiansen RL. Taste thresholds in patients with artificial dentures. J Am Dent Ass 1967; 75: 1118–20
Henkin RI. Taste localization in man. In: Bosma JF, editor. Oral sensation and perception II. Springfield: CC Thomas, 1969: 43–68
Henkin RI. Disorders of taste and smell. JAMA 1971; 218: 1946
Bosma JD, Henkin RI, Christiansen RL, et al. Hypoplasia of the nose and eyes, hyposmia, hypogeusia and hypogonado-trophic hypogonadism in two males. J Craniofac Genet Dev Biol 1981; 1: 153–84
Kostka V, editor. Aspartic proteinases and their inhibitors. New York: DeGruyter, 1985
Henkin RI. Effects of vapor phase pollutants on central nervous system and sense organ function. In: Finkel AJ, Duel WC, editors. Clinical implications of air pollution research. Acton: Publishing Sciences Group, 1976: 193–216
Henkin RI. Impairment of olfaction and of the tastes of sour and bitter in pseudohypoparathyroidism. J Clin Endocrinol Metab 1968; 28: 624–8
Farfel Z, Bourne HR. Pseudohypoparathyroidism: mutation affecting adenylyl cyclase. Min Electro Met 1982; 8: 227–36
Henkin RI. Abnormalities of taste and olfaction in various disease states. In: Kare MR, Maller O, editors. The chemical senses and nutrition. Baltimore: Johns Hopkins Press, 1967: 95–113
Zisman E, Henkin RI, Ross GT, et al. A biochemical similarity between chromatin negative gonadal dysgenesis and pseudohypoparathyroidism. Acta Endocrin Panamer 1970; 1: 59–71
Henkin RI, Lippoldt RE, Bilstad J, et al. A zinc protein isolated from human parotid saliva. Proc Natl Acad Sci USA 1975; 72: 488–92
Shatzman AR, Henkin RI. Gustin concentration changes relative to salivary zinc and taste in humans. Proc Natl Acad Sci USA 1981; 78: 3867–71
Henkin RI, Keiser HR, Jaffe IA, et al. Decreased taste sensitivity after D-penicillamine reversed by copper administration. Lancet 1967; 2: 1268–71
Henkin RI, Patten BM, Re P, et al. A syndrome of acute zinc loss. Arch Neurol 1975; 32: 745–51
Tomita H. Zinc in taste and smell disorders. In: Tomita H, editor. Trace elements in clinical medicine. Tokyo: Springer Verlag, 1990: 15–37
Henkin RI, Larson AL, Powell RD. Hypogeusia, dysgeusia, hyposmia and dysosmia following influenza-like infection. Ann Otol Rhinol Laryngol 1975; 84: 672–82
Walters E, Buchhert K, Maruniak JA. Olfactory cytochrome P450 immunoreactivity in mice is altered by dichlobenil but preserved by metyropone. Toxicology 1993; 81: 113–22
Dahl AR. The effect of cytochrome P450-dependent metabolism and other enzyme activities on olfaction. In: Margolis FL, Getchell TV, editors. Molecular neurobiology of the olfactory system. New York: Plenum Press, 1988: 51
Ding X, Coon MJ. Immunological characterization of multiple forms of cytochrome P450 in rabbit nasal microsomes and evidence for tissue specific expression of cytochrome P450 NMa and NMb. Mol Pharmacol 1990; 37: 489–96
Brittebo EB. Metabolism of xenobiotics in the nasal olfactory mucosa: implications for local toxicity. Pharmacol Toxicol 1993; 72 Suppl. 3:50–2
Erikkson C, Brittebo EB. Metabolic activation of the herbicide dichlobenil in the olfactory mucosa of mice and rats. Chem Biol Interact 1991; 79: 165–77
Henkin RI. The neuroendocrine control of perception. In: Hamburg DA, Pribram KH, Stunkard AJ, editors. Perception and its disorders. Vol 48. Baltimore: Williams & Wilkins Co, 1970:54–107
Henkin RI. The role of adrenal corticosteroids in sensory processes. In: Blaschko H, Sayer G, Smith AD, editors. Adrenal gland. Handbook of physiology, endocrinology. Vol 6. Washington: Am Physiol Soc, 1975: 209–30
McConnell RJ, Menendez CW, Smith FR, et al. Defects of taste and smell in patients with hypothyroidism. Am J Med 1975; 59: 354–64
Rivlin RS, Osnos M, Rosenthal S, et al. Abnormalities in taste preference in hypothyroid rats. Am J Physiol 1977; 1: E80–4
Hallman VL, Hurst JW. Loss of taste as toxic effect of methimazole (Tapazole) therapy. JAMA 1953; 152: 322
Schneeberg NG. Loss of sense of taste due to methylthiouracil therapy. JAMA 1952; 149: 1091–3
Varma VM, Grollman EF, Dai WL, et al. Taste loss after 1131 treatment for thyroid cancer. Clin Res 1992; 40: 417A
Varma VM, Dai WL, Henkin RI. Persistent taste abnormalities in patients with thyroid cancer after thyroidectomy and radioactive iodine (RAI) may be related to racial or age differences. Clin Res 1993;41:392A
Hamilton Jr CR, Henkin RI, Weir G, et al. Olfactory status and response to clomiphene in male gonadotrophin deficiency. Ann Intern Med 1973; 78: 47–55
Formari AJ, Avram MM. Altered taste perception in uremia. Trans Am Soc Artif Inter Organs 1978; 24: 385–8
Sumderman Jr FW. Current status of zinc deficiency in the pathogenesis of neurological, dermatological and musculo-skeletal disorders. Ann Clin Lab Sci 1975; 5: 132–45
Henkin RI, Schechter PJ, Friedewald WT, et al. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 1976; 272: 285–99
Henkin RI, Aamodt RI, Foster DM. The role of zinc in taste and smell, In: Prasad AS, editor. The clinical, biochemical and nutritional aspects of trace elements. New York: Alan N Liss Inc., 1982: 161–88
Solomons NW, Rosenberg TH, Sandstead HH, et al. Zinc deficiency in Crohn’s disease. Digestion 1977; 16: 87–95
Solomons NW, Rosenberg IH, Sandstead HH. Zinc nutrition in celiac sprue. Am J Clin Nutr 1976; 29: 371–6
Hambidge KM, Hambidge C, Jacobs M, et al. Low levels of zinc in hair, anorexia, poor growth and hypoguesia in children. Pediatr Res 1972; 6: 868–74
Atkin-Thor E, Goddard BW, O’Nion J, et al. Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 1978; 31: 1948–51
Mahajan SK, Prasad AS, Briggs WA, et al. Improvement of uremie hypogeusia by zinc: A double blind study. Am J Clin Nutr 1980; 33: 1517–21
Weisman K, Christensen E, Dreyer V. Zinc supplementation in alcoholic cirrhosis: a double blind clinical trial. Acta Med Scand 1979; 205: 361–6
Tomita H, Ishii T, Miyakogawa M. Zinc and taste disturbance. Trace Metal Metab 1975; 1: 61–8
Tomita H. Ageusia by zinc deficiency and therapy. Taste Smell 1977; 11: 40–3
Mahajan SK, Prasad AS, Rabbani P, et al. Zinc metabolism in uremia. J Lab Clin Med 1979; 94: 693–8
Mahajan SK, Gardiner WH, Abbasi AA, et al. Abnormal plasma and erythrocyte zinc distribution in uremia. Trans Am Sci Art Int Org 1978; 24: 50
Mahajan SK, Abassi A, Prasad AS, et al. Zinc metabolism and taste acuity in renal transplant recipients. Kidney Int 1983; 16 Suppl.: S310–4
Spinozzi NJ, Murray CL, Grupe SE. Altered taste acuity in children with end stage renal disease. Pediatr Res 1978; 12: 442
Eggert JV, Siegler RL, Edomkesmalee G. Zinc supplementation in chronic renal failure. Int J Paed Nephrol 1982; 3: 21–4
Bicknell JM, Wiggins RV. Taste disorder from zinc deficiency after tonsillectomy. West J Med 1988; 149: 457–60
Yoshida S, Endo S, Tomita H. A double blind study of the therapeutic efficacy of zinc gluconate on taste disorder. Auris Nasus Larynx 1991; 18: 153–61
Abe H, Tomita H. Experimental studies of taste disturbance due to food additives. Nihon Univ J Med Ass 1983; 29: 1–10
Zinc deficiency, Taste acuity and growth failure. Nutr Res 1978; 36:213–4
Campieri C, Ben Dardeff A, Prandini R, et al. Improvement of impotence, taste and olfactory defects in periodically hemodialyzed patients treated with zinc chloride [in Italian; abstract in English]. Minerva Nephrol 1980; 27: 377–82
Krueger KC. Hypogeusia and hyposmia associated with low serum zinc levels: a case report. JAMA 1980; 234: 109–11
Watson AR, Stuart A, Wells FE, et al. Zinc supplementation and its effect on taste acuity in children with chronic renal failure. Hum Nutr Clin Nutr 1983; 37: 219–25
Russell RM, Cox ME, Solomons N. Zinc and the special senses. Ann Intern Med 1983; 99: 227–39
Sprenger KBG, Bundschu D, Lewis K, et al. Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double blind study. Kidney Int 1983; 16 Suppl.: S315–8
Vreman HJ, Venter C, Leegwater J, et al. Taste, smell and zinc metabolism in patients with chronic renal failure. Nephron 1980; 26: 163–70
O’Nion J, Atkin-Thor E, Rothent SW. Effect of zinc supplementation on red blood zinc, serum zinc, taste acuity and dietary intakes in zinc deficient dialysis patients. Dial Transplant 1978; 7: 1208–13
Hasegawa M, Yamada K, Uchida H, et al. Mineral contents in the hair of taste disorder patients. Trace Metal Metab 1987; 15: 109–16
Mikoshiba H. Study of the movement of electrolytes and trace metals in parotid saliva of patients suffering from taste disorder. J Nihon Univ Med Ass 1984; 43: 509–18
Tomita H, Ishii T, Mikoshiba H, et al. Combined disorders of taste and smell. Otologia 1981; 27 Suppl. 1: 259–64
Tomita H. Combined disturbance of taste and smell. Taste Smell 1980; 14: 25–31
Henkin RI, Aamodt RL, Babcock AK, et al. Treatment of abnormal chemoreception in human taste and smell. In: Norris DM, editor. Perception of behavioral chemicals. Amsterdam: Elsevier/North-Holland Biomedical Press, 1981: 227–65
Babcock AK, Henkin RI, Aamodt RL, et al. The effects of oral zinc on zinc metabolism, II: in vivo kinetics. Metabolism 1982; 31: 335–47
Olmez I, Gulovali MC, Gordon GE, et al. Trace elements in human parotid saliva. Biol Trace Elem Res 1988; 17: 259–70
Law JS, Nelson N, Watanabe K, et al. Human salivary gustin is a potent activator of calmodulin-dependent brain phosphodiesterase. Proc Natl Acad Sci USA 1987; 84: 1674–8
Henkin RI. Zinc, saliva and taste: Interrelationships of gustin, nerve growth factor, saliva and zinc, In: Hambidge JM, Nichols BL, editors. Zinc and copper in clinical medicine. New York: Spectrum Publications Inc., 1978: 35–48
Shatzman AR, Henkin RI. Gustin concentration changes relative to salivary zinc and taste in humans. Proc Natl Acad Sci USA 1981; 78: 3867–71
Foster DM, Aamodt RL, Henkin RI, et al. Zinc metabolism in humans: A kinetic model. Am J Physiol 1979; 237: R340–9
Aamodt RL, Rumble WF, Johnston GS, et al. Absorption of orally administered Zn65 by normal human subjects. Am J Clin Nutr 1981; 34: 2648–52
Aamodt RL, Rumble WF, Babcock AK, et al. Effects of oral zinc loading on zinc metabolism in humans-I: Experimental studies. Metabolism 1982; 31: 326–34
Babcock AK, Henkin RI, Aamodt RL, et al. Effects of oral zinc loading on zinc metabolism in humans-II: In vivo kinetics. Metabolism 1982; 31: 335–47
Wastney ME, Aamodt RL, Rumble WF, et al. Kinetic analysis of zinc metabolism and its regulation in normal humans. Am J Physiol 1986; 251: R398–408
Wastney ME, Foster DM, Henkin RI. Identification of abnormal sites of zinc transport and metabolism in patients with sensory and endocrine disorders. In: Hurley LS, Keen CL, Lonnerdal B, et al. editors. Trace elements in man and animals 6. New York: Plenum Press, 1988: 53–4
Wastney ME, Henkin RI. Development and application of a model for zinc metabolism in humans. Prog Food Nutr Sci 1988; 12: 243–54
Gentle MJ. The effects of zinc deficiency on oral behavior and taste bud morphology in chicks. Br Poultry Sci 1881; 22: 265–73
Hasegawa H, Tomita H. Assessment of taste disorders in rats by simultaneous study of the two bottle preference test and abnormal ingestive behavior. Auris Nasus Laryx 1986; 13 Suppl. 1: S33–41
Hasegawa H, Kishi T, Tomita H. Abnormal taste reactivities in zinc deficient rats. Proc Jpn Ass Taste Smell 1980; 14: 69–71
Brosvic GM, Slotnick RM, Henkin RI. Decreased gustatory sensitivity in zinc deprived rats. Physiol Behav 1992; 52: 527–33
Pallauf J. Zinkgehalte in Knochen and Ganzkorper wachsender bei unterschiedliche Zinversorgung zum Stoffwechsel des Zinks in tierschen Organismus. Z Tierphysiol 1972; 30: 193–202
Kobayashi T, Tomita H. Electron microscopic observation of vallate taste buds of zinc-deficient rats with taste disturbance. Auris Nasus Larynx 1986; 13 Suppl. 1: S25–31
Naganuma M, Ikeda M, Tomita H. Changes in soft palate taste buds of rats due to aging and zinc deficiency-scanning electron microscopic observation. Auris Nasus Larynx 1988; 15: 117–27
Ohki M, Fujita S, Tomita H, et al. Turnover of taste buds of rats with taste disorders caused by zinc deficiency. Proc Jpn Symp Taste Smell 1988; 12: 41–4
Kobayashi T. Electron microscopic observation of vallate taste buds of zinc-deficient rats with taste disturbance. J Nihon Univ Med Ass 1983; 42: 557–64
Kishi T. Histochemical studies on the taste buds of zinc deficient rats. J Nihon Univ Med Ass 1984; 43: 15–31
Shigihara S, Tomita H. Electron microscopy of the olfactory epithelium in zinc deficient rats. Nihon Univ J Med Ass 1986; 28: 263–80
Mikoshiba H, Hosonuma H, Kobayashi T, et al. A quantitative study of zinc concentrations in the olfactory epithelium of nasal cavity and the central nervous system in zinc deficient rats. Trace Metal Metab 1983; 11: 1–4
Martin MFR, McKenna F, Bird HA, et al. Captopril: a new treatment for rheumatoid arthritis. Lancet 1984; 1: 1325–7
Packer M, Lee WH, Yushak M, et al. Comparison of captopril and enalapril in patients with chronic heart failure. N Engl J Med 1986; 315: 847–53
McFate Smith W, Kulaga SF, Mancloa F, et al. Overall tolerance and safety of enalapril. J Hypertens 1984; 2 Suppl. 5: 113–7
Currie WJC, Cooper WD. Safety of angiotensin-converting enzyme inhibitors. Lancet 1985; 1: 580–1
Johnston CI, Arnolda L, Hiwatari M. Angiotensin-con verting enzyme inhibitors in the treatment of hypertension. Drugs 1984; 27: 271–7
Hollenburg NK. Medical therapy of renovascular hypertension: efficiency and safety of captopril in 269 patients. Cardiovasc Rev Rep 1983; 4: 852–78
Groel JT, Tadros SS, Dreslinski GR, et al. Long-term antihy-pertensive therapy with captopril. Hypertension 1983; 5 Suppl. III: 145–51
Weinberger MH. Influence of an angiotensin converting enzyme inhibitor on diuretic induced metabolic effect in hypertension. Hypertension 1983; 5 Suppl. III: 132–8
Knill JR. The development of captopril and its role in the treatment of hypertension. Clin Exp Pharmacol Physiol 1983; 7: 63–71
Havelka J, Boerlin HJ, Studer A, et al. Long-term experience with captopril in severe hypertension. Br J Clin Pharmacol 1984; 14: 718–68
Abrams WB, Davies RO, Ferguson RK. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Fed Proc 1983; 43: 1314–21
Kono T, Oseko F, Ikeda F, et al. Effects of a new angiotensin-converting enzyme inhibitor, MK421, in normal men and patients. Endocrinol Jpn 1982; 29: 615–22
MacGregor GA, Markandu ND, Bayless J, et al. Non-sulfhy-dryl-containing angiotensin-converting enzyme inhibitor (MK 421); evidence for role of renin system in normotensive subjects. BMJ 1981; 283: 401–3
Croog SH, Levine S, Testa MA, et al. The effects of antihypertensi ve therapy on the quality of life. N Engl J Med 1986; 314: 1657–64
Edwards IR, Coulter DM, Beasley DMG, et al. Captopril: 4 years of post marketing surveillance of all patients in New Zealand. Br J Clin Pharmacol 1987; 23: 529–36
Frohlich DF, Cooper RA, Lewis EJ. Review of the overall experience of captopril on hypertension. Arch Intern Med 1984; 144: 1441–4
Jackson B, Maher D, Matthews PG, et al. Lack of cross sensitivity between captopril and enalapril. Aust N Z J Med 1988; 18: 21–7
Grosskopf I. Persistent captopril-associated taste alteration. Clin Pharm 1984; 3: 235
McNeil JJ, Anderson A, Christophidis N, et al. Taste loss associated with oral captopril treatment. BMJ 1979; 15: 1555–6
Classes PH, Ferguson RK. Temporary ageusia related to captopril. Lancet 1979; 2: 526
Ondeti MA, Rubin B, Cushman DW. Design of specific inhibitors on angiotensin-converting enzyme: mechanism of orally active antihypertensive agents. Science 1977; 196: 441–4
Abu-Hamdan DK, Desai H, Sondheimer J. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens 1987; 1 (Pt 3): 303S–308S
Brunner HR, Waeber B, Wautera JP, et al. Inappropriate renin secretion unmasked by captopril (SQ 14225) in hypertension of chronic renal failure. Lancet 1971; 2: 704–7
Gavras H, Brunner HR, Turini GA, et al. Antihypertensive effect of the oral angiotensin converting enzyme inhibitor (AQ 14225) in man. N Engl J Med 1978; 298: 991–5
Zazgornick J, Kaiser W, Biesenbach G. Captopril induced dysgeusia. Lancet 1992; 341: 1542
Patchen AA, Harris E, Tristam EW. A new class of angiotensin-converting enzyme inhibitors. Nature 1980; 288: 280–3
Gross DM, Sweet CS, Ulm EH, et al. Effect of N-[(S)-l-car-boxy-3 phenylpropyl] 1-Ala-1-Pro and its ethyl ester [MK-421] on angiotensin converting enzyme in vitro and angiotensin 1 pressor responses in vivo. J Pharmacol Exp Ther 1981; 216: 552–7
Stumpe KO, Kolloch R, Overlack A. Captopril and enalapril: Evaluation of therapeutic efficacy and safety. Pract Cardiol 1984; 10: 260–9
Gomez HJ, Cirillo VJ, Irvin JD. Enalapril: a review of human pharmacology. Drugs 1985; 30 Suppl. 1: 13–24
Edwards CRW, Padfield PL. Angiotensin-converting enzyme inhibitors: past, present and bright future. Lancet 1985; 55 Suppl. 1:30–4
Robertson JIS. Summary. Br J Clin Pharmacol 1984; 18 Suppl. 2: 257S–259S
McFate Smith W, Davies RO, Gabriel MA, et al. Tolerance and safety of enalapril. Br J Pharmacol 1984; 18 Suppl. 2: 249S–255S
Packer M. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic. Int J Cardiol 1985; 7: 111–20
Classes PH, Larigani GE, Conner DP, et al. Enalapril, a non-sufhydryl angiotensin-converting enzyme inhibitor. Clin Pharm 1985; 4: 27–40
Dollery CT. Safety and efficacy of enalapril. J Hypertens 1983; 1 Suppl. 1: 155–7
Davies RO, Irvin JD, Kramsch DK, et al. Enalapril worldwide experience. Am J Med 1984; 77: 23–35
Perrone C, Gerbaud L, Leport C, et al. Dysgeusia during treatment with enalapril. Therapie 1989; 44: 67
Boyd O. Captopril induced taste disturbance. Lancet 1993; 342: 304
Enalapril (Vasotec). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1553
Fosinopril (Monopril). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1386
Lisinopril (Zestril). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2339
Levenson JL, Kennedy K. Dysosmia, dysgeusia and nifedipine. Ann Intern Med 1985; 102: 135–6
Henkin RI, Graziadei PPG, Bradley DF. The molecular basis of taste and its disorders. Ann Intern Med 1969; 71: 791–821
Procardia XL (Nifedipine). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1796
Nifedipine (Adalat). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1566
Ikeda M, Tomita H, Sekimoto K. Drug-induced taste disorder: Due to zinc chelation? In: Tomita H, editor. Trace elements in clinical medicine. Tokyo: Springer Verlag, 1990: 255–60
Diltiazem (Cardizem). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1294
Wistrand PJ. The use of carbonic anhydrase inhibitors in ophthalmology and clinical medicine. Ann NY Acad Sci 1984; 424: 609–19
Joyce PW, Mills KH. Comparison of the effect of acetazolamide tablets and Sustets on diurnal intraocular pressure in patients with chronic simple glaucoma. Br J Opthalmol 1990; 74: 413–6
Joyce PW. Taste disturbance with acetazolamide. Lancet 1990; 336: 1446
Lichter PR. Reducing side-effects of carbonic anhydrase inhibitors. Opthalmology 1981; 88: 266–9
McMurdo MET, Hutchison GL, Lindsay G, et al. Taste disturbance with acetazolamide. Lancet 1990; 336: 1190–1
Miller LG, Miller SM. Altered taste secondary to acetazolamide therapy. J Fam Pract 1990; 31: 199–200
Acetazolamide (Diamox). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1157
Hansson HPJ. On the effect of carbonic anhydrase inhibition on the sense of taste: an unusual side effect of a medication. Nord Med 1961; 65: 65–7
Graber M, Kelleher S. Side effects of acetazolamide, the champagne blues. Am J Med 1988; 84: 979–80
Schiffman SS. Taste and smell in disease. N Engl J Med 1983; 308: 1275–9
Shiffman SS, Lockhead E, Maer FW. Amiloride reduces the taste intensity of Na+ and Na+ salts and sweeteners. Proc Natl Acad Sci USA 1983; 80: 6136–40
Chlorthalidone (Temoretic). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2633
Chlorthalidone (Thalitone). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1046
Gifford RW. Ethacrynic acid alone or in combination with methyldopa in management of mild hypertension: a report of 23 patients. Int Z Klin Pharmakol Ther Toxik 1970; 3: 255–60
Furosemide (Lasix). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1042
Pak C, Ruskin B, Diller E. Enhancement of renal excretion of zinc by hydrochlorothiazide. Clin Chem Acta 1972; 39: 511–7
Mattes RD, Engleman K. Effects of combined hydrochlorothiazide and amiloride versus single drug on changes in salt taste and intake. Am J Cardiol 1992; 70: 91–5
Mattes RD, Christensen CM, Engelman K. Effects of hydrocholorothiazide and amiloride on salt taste and excretion (intake). Am J Hypertens 1990; 3: 436–43
Henkin RI. Drug effects on taste and smell. In: Pradham SN, Maickel RP, Dutta SN, editors. Pharmacology in medicine: principles and practice. Bethesda: SP Press Int., 1986: 748–53
Clee MD, Burrow L. Taste and smell in disease. N Engl J Med 1983;309: 1062
Triamterine (Maxide). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1168
Sekimoto K, Tomita H. Zinc chelation of hypotensive agents causing taste disturbance. Nihon Univ J Med Ass 1986; 28: 233–52
Martino E, Aghini-Lombardi F, Maricotti S, et al. Amiodarone iodine-induced hypothroidism: risk factors and follow-up in 28 cases. Clin Endocrinol (Oxf) 1987; 26: 227–37
Gentykow GD, Sullivan JY. Extracardiac adverse effects of flecainide. Am J Cardiol 1984; 53: 101B–105B
Flecainamide (Tambocor). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1282
Mexilitine (Mexitil). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 616
Moricizine HC1 (Ethmozine). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1872
Procainamide (Procan SR). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1769
Cholestyramine (Questran). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 642
Gastpar H. Drug effects on the nasal mucosa and sense of smell [in German; abstract in English]. Laryngorhinootologie 1986; 65: 415–9
Clofibrate (Atromid S). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2517
Gemfibrozil (Lopid). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1752
Lovastatin (Mevacor). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1490
Weber R. Toxic drug-induced hyposmia with lovastatin [in German; abstract in English]. Laryngorhinootologie 1992; 71: 483–4
Pravachol (Pravastatin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2320
Kinney EL, Carlin B, Ballard JO, et al. Clinical experience with amrinone in patients with advanced congestive heart failure. J Clin Pharmacol 1982; 22: 433–40
Diazoxide (Hyperstat IV). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2146
Dipyridamole (Persantin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 619
Doxozosin (Cardura). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1971
Whittington J, Raftery EB. A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris. Br J Clin Pharmacol 1980; 10: 211–5
Isosorbide mononitrate (Monoket). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2183
Ewing RC, Janda SM, Henamon NE. Ageusia associated with transdermal nitroglycerine. Clin Pharm 1989; 8: 146–7
Rabe F. Isolierte Ageusie. Ein neues Symptom als Nebenwirkung von Medikamenten. Nervenarzt 1970; 41: 23–7
Grand A. Chlorhydrate d’oxyfedrine et trouble du gout. Nouv Presse Med 1972; 1: 1944
Becker F, Kirsten G. Die Wirkung von Ildamen und Seda-ildamen bei coronarkranken in Klinik und Practis. Fortschr Med 1968; 19: 723–31
Scott PJ. Glossitis with complete loss oftaste sensation during dindevan treatment. Report of a case. N Z Med J 1960; 59: 291–6
Labetalol (Trandate). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 478
Durand MV. Anosmie recurrente sous beta-bloquers. Presse Med 1985; 14: 2064
Henkin RI. Zinc in taste function: a critical review. Biol Trace Elem Res 1984; 6: 263–80
Shatzman AR, Henkin RI. Metal binding characteristics of the parotid salivary protein gustin. Biochim Biophys Acta 1980; 623: 107–18
Henkin RI, Law, JS, Nelson NR. The role of zinc on the trophic growth factors nerve growth factor and gustin. In: Hurley LS, Keen CL, Lonnerdal B, et al. Trace elements in man and animals 6. New York: Plenum Press, 1988: 385–8
Smit AJ, Hoorntje SJ, Donker AJM. Zinc deficiency during captopril treatment. Nephron 1983; 34: 196–7
Amlodipine (Norvasc). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1785
Berman JL. Dysosmia, dysgeusia and diltiazem. Ann Intern Med 1985; 102:717
Wester PO. Zinc during diuretic treatment. Lancet 1975; 8: 587
Orita M. Diuretics, Pharmaceutical Development Basic Lectures, VII(II). The current situation of new drugs, and the trends (part I) [in Japanese]. Chijin Shoin 1972: 421–41
Solomons NW. Zinc and human nutrition. In: Korcioglu ZA, Sarper RM, editors. Zinc and Copper in Medicine. Springfield: CC Thomas, 1980: 224–75
Henkin RI. Zinc in humans. In: Henkin RI, Apgar J, Cole JF, et al., editors. Zinc. Baltimore: University Park Press, 1979: 123–72
Giroux EL, Henkin RI. Competition for zinc among serum albumin and amino acids. Biochim Biophys Acta 1972; 273: 64–72
Henkin RI. Metal-albumin-amino acid interactions: Chemical and physiological interrelationships. In: Friedman M, editor. Protein-Metal interactions. New York: Plenum Publishing Co, 1974:299–328
Henkin RI. New aspects in the control of food intake and appetite. Ann NY Acad Sci 1977; 300: 321–34
Catalanotto FA, Henkin RI. Effects of thiols on sodium chloride preference and copper and zinc metabolism in the rat. Am J Physiol 1972; 222: 1594–8
Karin A, Brown EA. Isolation and identification of novel sulfur-containing metabolites of spironolactone (aldactone). Steroids 1972; 20: 41–62
Metolazone (Mykrox). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 936
Duncan RB, Briggs M. Treatment of uncomplicated anosmia by vitamin A. Arch Otolaryngol 1962; 73: 116–20
Henkin RI, Smith FR. Hyposmia in acute viral hepatitis. Lancet 1971; 1: 823–6
Henkin RI, Laster L. Relationship between vitamin A metabolism and decreased olfactory detection sensitivity in patients with abetalipoproteinemia and other type of malabsorption. J Clin Invest 1967; 46: 1069
Briggs MH, Duncan RB. Odour receptors. Nature 1961; 191: 1310–1
Smith CG. The change in volume of the olfactory and the accessory olfactory bulbs of the albino rat. J Comp Neurol 1935; 61: 477–508
Moulton DC. Pigment and the olfactory mechanism. Nature 1962; 195: 1312–3
Briggs MH, Duncan RB. Pigment and the olfactory mechanism. Nature 1962; 195: 1313–4
Bernard R, Halpern B. Taste changes in vitamin A deficiency. J Gen Physiol 1968; 52: 444–64
Goy JJ, Finci L, Sigwart U. Dysgeusia after high dose dipyri-damole treatment. Arzneimittelforschung 1985; 35: 854
Anggard E. Nitric oxide: mediator, murderer and medicine. Lancet 1994; 343: 1199–1206
Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–12
Bredt DS, Hwang PM, Glatt CE, et al. Cloned and expressed nitric oxide synthetase structurally resembles cytochrome P450 reductase. Nature 1991; 351: 714–8
Amiodarone (Cardavone). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2528
Beddows SA, Page SR, Taylor AH, et al. Cytotoxic effects of amiodarone and desethylamiodorone on human thymocytes. Biochem Pharmacol 1989; 38: 4397–403
Kirsner JB. Sulfamethazine-related dysgeusia. JAMA 1979; 241: 837
Henkin RI. Sulfamethazine-related dysgeusia. JAMA 1979; 247: 837
Rollin H. Drug-related gustatory disorders. Ann Otol Rhinol Laryngol 1978; 87: 37–42
Mott AE, Leopold DA. Disorders in taste and smell. Med Clin North Am 1991; 75: 1321–53
Jacobi GH, Moergel K. Azulfedine und isolierte ageusie fur die Geschmachsqualitat suss. Internist Praxis 1976; 16: 379–80
Sulfisoxazole (Gantrasin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1928
Farr M, Symmons DPM, Blake DR, et al. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine. Am Rheum Dis 1986; 45: 761–4
Bliddal H, Eiberg B, Helin P. Gold-induced leucopenia may predict similar adverse reaction to sulfasalazine. Lancet 1987; 1:390
Jaffe IA. Ampicillin rashes. Lancet 1970: 1: 245
Jojart G. Sense of smell after gentamycin nose-drops. Lancet 1992; 339: 313
Manzo E. Azione della kananicini solo organo dell olfactto. Richerike Sperimentali. Arch Ital Otol 1960; 68: 305–21
Castello R. Effetti della neurotossicita della streptomicina i didro streptomicina sulla fungione olfattiva. Minerva Otorhinolaryng 1956; 6: 129–35
Rapuzzi G, Bruschi ML. Azione della streptomicine sul-l’attevita del recettori linguali di rana. Bull del Soc Ital Biol Spermet 1970; 46: 417–20
Amoxicillin (Augmentin). Physicans Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2242–4
Kerrebijn KF. Ampicillin rashes. Lancet 1970; 1: 245
Shapiro S, Siskina V, Sloane D, et al. Drug rashes with ampicillin and other penicillins. Lancet 1969; 2: 969–72
Lankin DL, Jewell GM, Grinvalsky HT. Psychotic-like reaction to procaine penicillin G. Ann Emerg Med 1983; 8: 507
Tompsett R. Pseudoanaphylactic reactions to procaine penicillin G. Arch Intern Med 1967; 120: 565–7
Piperacillin/Tazalactan (Zosyn). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994; Suppl. B: 33–40
Mall T, Witt M, Follath F. Reversible ageusia during cefecetril therapy [in German]. Dtsch Med Wochenschr 1983; 108: 1698
Cefadroxil (Duricef)- Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1799
Hodgson TG. Bad taste from cefamandole. Drug Intell Clin Pharm 1981; 15: 136
Cefpodoxine (Vantin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2453
Ceftriaxone (Rocephin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2003
Cephalexin (Keftab). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 873
Enoxacin (Penetrex). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1861
Ofloxcacin (Floxin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1349–59
Clarithromycin (Biaxin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 405
Bleasel AF, McLeod JG, Lane Brown M. Anosmia after doxycycline use. Med J Aust 1990; 152: 440
Magnasco LD, Magnasco AJ. Metallic taste with tetracycline therapy. Clin Pharmacy 1985; 4: 455–6
Abnormalities of taste. BMJ 1976; 2: 198
Amphotericin B (Fungizone). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 517
Henkin RI. Griseofulvin and dysgeusia: implications. Ann Intern Med 1971; 74: 795–6
Fogan L. Griseofulvin and dysgeusia: implications? Ann Intern Med 1971; 74: 795
Juhlin L. Loss of taste and terbinafine. Lancet 1992; 339: 1483
Back D. Loss of taste and terbinafine [letter]. Lancet 1992; 340: 252
Ottervanger J, Stricker BH. Loss of taste and terbinafine. Lancet 1993; 340: 728
Rauch S, Cada K. Tuberkulostatika. Hals-Nasen-Öhren-Heilkunde. In: Kuemmerle HP, Gossens N, editors. Klinik und Therapie der Nebenwirkungen. Stuttgart: Thieme, 1973: 310
Rollin H. Funkionsprufungen und Storungen des Geschmackssinnes. Arch Otol Rhinol Laryngol 1975; 210: 165–218
Girling DJ. Adverse effects of antituberculosis drugs. J Antimicrob Chemother 1982; 23: 56
Didanosine (Videx). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 645
Foscarnet (Foscavir). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 547
Simpson JR. Idoxuridine in the treatment of herpes zoster. Practitioner 1975; 215: 226–9
Interferon alfa-n3 (Alferon N). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1813
Rimantadine (Flumadine). American Hospital Formulary. Bethesda: American Society of Pharmacists, 1994: 427
Zalcitabine (HIVID). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1929–35
Zidovudine (Retrovir). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 742
Metronidazole (Flagyl). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2208
Scott AE. Clinical characteristics of taste and smell disorders. Ear Nose Throat J 1985; 68: 297–315
Strassman HD, Adams B, Pearson AW. Metronidazole effect on social drinkers. Q J Stud Alcohol 1970; 31: 394–8
Goldman P. Metronidozol. N Engl J Med 1980; 303: 1212–8
Prata A. Clinical evaluation of niridazole in Schistosoma mansoni infection. Ann NY Acad Sci 1969; 160: 660–9
Manson-Bahr PE. Antiprotozoal drugs. In: Meyler L, Herxheimer A, editors. Side effects of drugs. Vol 7. Amsterdam: Excerpta Medica, 1971: 411
Pentamidine (Nebupent). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 969
Pentamidine (Pentam). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 970
Gordon II BL, Yanagihara R. Treatment of systemic lupus erythematosis with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum of four months. Ann Allergy 1977; 39: 227–36
Runge LA. Pinals RS, Lourie SH, et al. Treatment of rheumatoid arthritis with levamisole: a controlled trial. Arthritis Rheum 1977; 20: 1445–8
Levamisole (Ergamisol). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1087
Van Belle H. Kinetics and inhibition of alkaline phosphatases from canine tissues. Biochim Biophys Acta 1972; 289: 158–68
Van Belle H. Kinetics and inhibition of rat and avian alkaline phosphatases. Gen Pharmacol 1976; 7: 53–8
Flotra L, Gjermo P, Rolla G, et al. Side effects of chlorhexidine mouth washes. J Dent Res 1971; 79: 119–25
Lang NP, Catalanotto FA, Knopfli RU, et al. Quality-specific taste impairment following the application of chlorhexidine digluconate mouth rinses. J Clin Periodontol 1988; 15: 43–8
O’Neil TCA. The use of chlorhexidine mouthwash in the control of gingival inflammation. Br Dent 1976; 3: 141: 276
Hepso HU, Bjornland T, Skoglund LA. Side effects and patient acceptance of 0.2% vs. 0.1 % chlorhexidine used as post operative prophylactic mouthwash. Int J Oral Maxillofac Surg 1988; 17: 17
Plath P, Otten Z. Untersuchungen über die Wirksamkeit von Hexetine bei akuten Erkrankungen des Rachens um der Mundhohle sowie nach Tonsillektomie. Ther Woche 1969; 19: 1565–6
Bergenholtz A, Hanstrom L. The plaque inhibiting effect of hexitidine (Oraldene) mouthwash compared to that of chlorhexidine. Comm Dent Oral Epidemiol 1974; 2: 70
Ciprofloxocin (Cipro). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1570
Beidler LM, Smallman R. Renewal of cells within taste cells. J Cell Biol 1965; 27: 263–72
Moulton DG. Cell renewal in the olfactory epithelium of the mouse. In: Denton DA, Koghlan JP, editors. Olfaction and taste V. New York: Academic Press, 1975: 111–4
Moulton DG, Celebi G, Fink RP. Olfaction in mammals — two aspects: proliferation of cells in the olfactory epithelium and sensitivity to odours. In: Wolstenholme GEW, Knight J, editors. Taste and smell in vertebrates. London: Churchill, 1970: 227–50
Moulton DG, Fink RP. Cell proliferation and migration in the olfactory epithelium, In: Schneider D, editor. Olfaction and taste IV. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1972:20–26
Moulton DG. Dynamics of cell populations in the olfactory epithelium. Ann NY Acad Sci 1974; 237: 52–61
Mulvaney BD, Heist HE. Regeneration of rabbit olfactory epithelium. Am J Anat 1971; 131: 241–52
Graziadei PPC. Cell dynamics in the olfactory mucosa. Tissue Cell 1973; 5: 113–31
Pratt WB. Chemotherapy of infection. New York: Oxford University Press, 1977:128–175
Seydell EM, Mecknight WP. Disturbances of olfaction resulting from intranasal use of tyrothricin. Arch Otolaryngol 1948; 47: 465–70
Weitzel C, Streikem FJ, Roester U, et al. Zink in Tepetum Lucidum. Hoppe-Zeyler’s Z Physiol Chem 1964; 296: 19–30
Ketoconazole (Nizoral). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1095
Back DJ, Teja JF. Azalez and allylamines: the clinical implications of interaction with cytochrome P-450 enzymes. J Dermatol Treat 1990; 1 Suppl. 2: 11–3
Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330: 263–72
Loose DS, Kan PB, Hirst MA, et al. Ketoconozole blocks adrenal steroidogenesis inhibiting cytochrome P450 dependent enzymes. J Clin Invest 1983; 71: 1495–9
MacLean JH, Shipley MT, Bernstein DJ. Transnasal, transneuronal transport of herpes simplex virus type I into the rat brain. Soc Neurosci Abst 1987; 13: 1399
Gebhardt BM, Hall JM. Cellular neuroimmunologic reponses to ocular herpes simplex virus infection. J Neuroimmunol 1990; 28: 227–36
Stroup WG, Rock DL, Finzer NW. Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute latent infections by in situ hybridization. Lab Invest 1984; 51: 27–38
Kanda Y, Shigeno K, Kinoshita N, et al. Sudden hearing loss associated with interferon. Lancet 1994; 343: 1134–5
Calvet MC, Gresser I. Interferon enhances the excitability of cultured neurons. Nature 1979; 278: 558–60
Schattner A. Interferon on autoimmunity. Am J Med Sci 1989; 295: 532–44
Conton KC, Urba WJ, Smith II JW, et al. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990; 65: 2237–42
Borgers M. The cytochemical application of new potent inhibitors of alkaline phosphatases. J Histochem Cytochem 1973; 21: 812–24
Glenney Jr JR. Tyrosine-phosphorylated proteins: mediators of signal transduction from the tyrosine kinases. Biochim Biophys Acta 1992; 1134: 113–27
Fischer EH, Charbonneau H, Tonks NK. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1991; 253: 401–6
Lum CKL, Henkin RI. Characterization of fractions from bovine taste buds and epithelial tissue: Relationships to bioactivity. Biochim Biophys Acta 1976; 421: 362–79
Needleman M, Rez A. Thromboxanes: selective biosynthesis and distinct biological properties. J Clin Invest 1976; 193: 163–5
Bourliere F, Cendron H, Rapaport A. Action de l’acide acetylsalicylique sur la sensibilite au gout amer chez l’homme. Rev Fr Etud Clin Biol 1959; 4: 380–2
Rapaport A. Effet du salicylate de soude sur la reponse primaire du rat blanc aux stimuli amers. C R Soc Biol (Paris) 1956; 150: 2182–6
Chalopin H, Sodigne G, Nigeon-Dureuil M. Action de l’ion Sodium du salicylate de Sodium sur le rat normal aulsurrenalectomise soumis au froid et a l’inanition. J Physiol 1958; 50: 209–12
Hellekant G, Gopal V. Depression of taste responses by local or intravascular administration of salicylates in the rat. Acta Physiol Scand 1975; 95: 286–92
Song MK, Adham NF. Role of prostaglandin E in zinc absorption in the rat. Am J Physiol 1978; 234: E99–105
State FA. Effect of indomethacin on the histological structure and cholinesterase activity of taste buds. Acta Anat (Basel) 1980: 106: 30–4
Ibuprofen (Nuprin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 684
Ketoprofen (Orudis). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2571
Straza JA, Ressetar M. Butazolidine in the treatment of arthritis. J Med Soc NJ 1953; 50: 333–4
Rechenberg V. Butazoldin. Thieme, Stuttgart, 1961: 102
Diclofenac (Voltarin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 996
Etodolac (Lodine). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2551–3
Flurbiprofen (Ansaid). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2393
Ketorolac (Toradol). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2372
Misoprostol (Cytotec). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2197
Nabumetone (Relafen). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2275
Oxaprozin (Daypro). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2199
Piroxicam (Feldene). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1792
Sulindac (Clinoril). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1415
Beclomethasone (Beconase aerosol). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 475
Flunisolide (Aerobid, Aerobid-M). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 948
Drettner B, Ebbesen A, Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982; 20: 149–58
Pirbuterol (Maxair Inhaler). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1278
Behrend T. Was iest gesichert in der Behandlung der chronischen entzündlichen Gelenkerkrankungen? Internist (Berl) 1972; 13:473–80
Witzgall H. Goldbehandlung des chronischen Gelenkrheumatismus. Internist (Berl) 1967; 8: 250–3
Hochberg MC. Auronofin or D-penicillamine in treatment of rheumatoid arthritis. Ann Intern Med 1986; 105: 528–35
Gold sodium thiomalate (Myochrysine). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1501
Grootveld M, Blake DR, Sahinoglu T, et al. Control of oxidative damage in rheumatoid arthritis by gold(I)-thiolate drugs. Free Radic Res Comm 1990; 10: 199–220
Sternlieb I, Scheinberg H. Penicillamine therapy for hepato-lenticular degeneration. JAMA 1964; 189: 748–54
Keiser HR, Henkin RI, Kare MR, et al. Loss of taste during therapy with penicillamine. JAMA 1968; 203: 381–3
Gutierrez Fuentes JA. Ageusia as a secondary manifestation of treatment with D-penicillamine fin Spanish; abstract in English]. Res Clin Esp 1984; 172: 149–51
Jaffe IA. The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum 1970; 13: 436–43
Huskisson FC, Hart FD. Penicillamine in the treatment of rheumatoid arthritis. Ann Rheum Dis 1972; 31: 402–4
Jaffe IA. Effects of penicillamine on the kidney and on taste. Postgrad Med J 1968; 44: 15–8
Taisch G, Broil H, Eberl R. D-penicillamine (Artimen) als Basistherapie bei chronischer Polyarthritis. Wien Klin Wschr 1973; 85: 59–63
Multicenter Trial Group. Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet 1973; 1: 275–80
Miehlke K, Jentsch D. D-penicillamine-Therapie bei entzündlichen rheumatischen Krankheiten. Dtsch Arztbl 1975; 1207–12
Lyle WH. Penicillamine and zinc. Lancet 1974; 2: 1140
Penicillamine (Cupramine). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1424
Kare MR, Henkin RI. The effects of D-penicillamine on taste preference and volume intake of sodium chloride by the rat. Proc Soc Exp Biol Med 1969; 131: 559–65
Zawalich WS. Gustatory nerve discharge and preference behavior of penicillamine treated rats. Physiol Behav 1971; 6: 419–23
Ito H. Preference behavior and taste nerve responses in D-penicillamine treated rats. Physiol Behav 1978; 21: 574–9
Allopurinol (Zyloprim). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 772
Colchicine. Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1214
Beidler LJ, Nejod MS, Smallman RL, et al. Rat taste cell proliferation [abstract]. Fed Proc 1960; 19: 302
Henkin RI, Bradley DF. Hypogeusia corrected by Ni++ and Zn++. Life Sci 1970; 9: 701–9
Henkin RI, Bradley DF. Regulation of taste acuity by thiols and metal ions. Proc Natl Acad Sci USA 1969; 62: 30–7
Huskisson EC, Jaffe IA, Scott J, et al. 5-thiopyridoxine in rheumatoid arthritis: clinical and experimental studies. Arthritis Rheum 1980; 23: 106–10
Malawista SE. The action of colchicine in acute gouty arthritis. Arthritis Rheum 1975; 18 Suppl. 6: 835–46
Neundorfer B. Disorders of smell and taste in treatment with thiamazole and carbimazole [in German]. Nervenarzt 1987; 58: 61–2
Leys D. Hyperthyroidism treated with methythiouracil. Lancet 1945; 1: 461–4
Grossman S. Loss of taste and smell due to prophythiouracil therapy. NY State J Med 1953; 53: 1236
Frawley TF, Keopf GF. Neurotoxicity due to thiouracil and thiomen derivatives. Case report. J Clin Endocrinol 1950; 10: 623–5
Isbister J, Rundle FF. Antithyroid therapy: clinical trials with ‘mercazole’. Med J Aust 1954; 1: 78
Kruskemper HL. Nebenwirkungen thryrenstatischen Arzneimittel. Internist 1966; 1: 436–42
Ruhdorff KH. Geruchs und Geschmacksstörungen durch Thiamazol. Dstch Med Wschr 1979; 104: 408
Varma VM, Dai WL, Henkin RI. Persistent taste abnormalities in patients with thyroid cancer after thyroidectomy and radioactive iodine (RAI) may be related to racial or age differences in parotid saliva(s) RAI. Clin Res 1993; 41: 392A
Ferguson AW, de la Harpe PL, Farquar JW. Dimethyldiguanide in the treatment of diabetic children. Lancet 1961; 1: 1367–9
Haller H, Strauzenberg SE. Orale Diabetes Therapie. Leipzig: Thieme, 1966
Weller C, Macanlay A. Preliminary clinical observations on the use of a biguanide (DBI) as an oral hypoglycemic agent. J Am GeriatSoc 1959; 7: 128–36
Lahon HFJ, Mann RD. Glipizide: results of a multicentre clinical trial. J Int Med Res 1973; 1: 608–15
Gazzola G. Duecasi di ageusia d’insulin-terapia. Arch Psicolog Neurol Psychiatr 1952; 13: 104
Tolbutamide (Orinase). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2438
Diazoxide (Proglycem). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 576
Halter J, Kulkosky P, Woods S, et al. Afferent receptors, taste perception and pancreatic endocrine function in man. Diabetes 1975; 24: 414
Le Floch JR, Lievre GL, Sadoun J, et al. Taste impairment and related factors in type I diabetes mellitus. Diabetes Care 1989; 12: 173–8
Henkin RI, Earll JM. Abnormalities of sugar recognition and perception in patients with type II diabetes. Clin Res 1987; 35: 578A
Cohen AM, Shafrir T. Comparison of free fatty acid and glucose response in diabetic patients treated with phenethy-formamidimyliminourea HC1(DBI) Isr Med J 1962; 21: 28
Wray HL, Harry AW. Adenosine 3′5′ monophosphate-dependent protein kinase in adipose tissue: inhibition by tolbutamide. Biochem Biophys Res Comm 1973; 53: 291–4
Lasseter KC, Levey GS, Palmer RF, et al. The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinge fiber automaticity and adenyl cyclase activity from rabbit and human hearts. J Clin Invest 1972; 51: 2429–34
Mertz W. Chromium. Physiol Rev 1969; 49: 164–231
Olmez I, Gulovali MC, Gordon G, et al. Trace elements in human saliva. In: Hemphill DD, editor. Trace Substances in Environmental Health XII. Columia: University of Missouri Press, 1978:231–240
Henkin RI, Gill Jr JR, Bartter FC. Studies on taste thresholds in normal man and patients with adrenal cortical insufficiency: The effects of adrenocorticosteroids. J Clin Invest 1963; 42: 727–35
Henkin RI, Bartter FC. Studies on olfactory thresholds in normal man and in patients with adrenal cortical insufficiency: The role of adrenal cortical steroids and of serum sodium concentration. J Clin Invest 1966; 45: 1631–9
Pruszewicz A, Kosowicz J. Quantitative and qualitative studies of the taste and smell in adrenal insufficiency. Endokrynol Pol 1966; 17: 321–327
Ezeh PI. Effect of steroids on the olfactory function of the dog. Physiol Behav 1992; 51: 1183–7
Henkin RI. The effects of corticosteroids and ACTH on sensory systems. In: De Wied D, Weijnen WM, editors. Progress in brain research. Amsterdam: Elsevier, 1970: 270–94
Henkin RI. The neuroendocrine control of perception. In: Hamburg DA, Pribram KH, Stunkard AJ, editors. Perception and its disorders. Baltimore, Williams and Wilkins, 1970: 54–107
Henkin RI. The role of adrenal corticosteroids in sensory processes. In: Blaschko H, Sayers G, Smith AD, editors. Handbook of physiology. Vol 6. Adrenal gland. Washington DC: American Physiology Society 1975: 209–30
Henkin RI. The metabolic regulation of taste acuity. In: Pfaffmann C, editor. Olfaction and taste III. New York: Rockefeller University Press, 1969: 574–85
Henkin RI, Fontana JA, Walker MD. On the mechanism of the presence and distribution of adrenal corticosteroids in the central and peripheral nervous system. Proceedings of the Third International Congress on Hormonal Steroids; 1970 Sept 7–12: Hamburg. Amsterdam: Excerpta Medica, 1971: 954–67
Henkin RI, Bradley DF. On the mechanism of action of carbohydrate active steroids on tastant detection and recognition. In: Sawyer C, Gorski R, editors. Steroid hormones and brain function. New York: Marcel Dekker, 1971: 225–311
Cooper DS. Antithyroid drugs. N Engl J Med 1980; 311: 1353–62
Reck R. Reversible loss of taste as a side effect in thiamazole therapy. Fortschr Med 1982; 100: 444–5
Erikssen J, Seegaard E, Naess K. Side-effect of thiocarbamides. Lancet 1975; 1: 231–3
Harris H, Kalmus H, Trotter WF. Taste sensitivity to phenylthiourea in goitre and diabetes. Lancet 1949; 2: 1038–9
McCarrison R. The thyroid gland in health and disease. London: Tindall and Co., 1917:178
Fischer R, Griffin F. Taste blindness and variations in taste threshold in relation to thyroid metabolism in normal and mentally ill populations. J Neuropsychiat 1960; 3: 98–104
Pittman JA, Beschi RJ. Taste thresholds in hyper-and hypothyroidism. J Clin Endocrinol Metab 1967; 27: 893–6
Mattes RD, Heller AD, Rivlin RS. Abnormalities in supra-threshold taste function in early hypothyroidism. In: Meiselman HL, Rivlin RS, editors. Clinical measurement of taste and smell. New York: MacMillan, 1986: 467–86
Henkin RI. Effects of ACTH, adrenocorticosteroids and thyroid hormone on sensory function. In: Stumpf W, Grant L, editors. Anatomical neuroendocrinology. Basel: S Karger, 1975:298–316
Beard MD, MacKay-Sim A. Loss of sense of smell in adult hypothyroid mice. Dev Brain Res 1987; 36: 18–189
Walker P, Weichsel Jr ME, Fisher DA, et al. Thyroxine increases nerve growth factor concentration in adult mouse brain. Science 1979; 204: 427–9
Walker P, Weil ML, Weichsel Jr ME., et al. Effect of thyroxine on nerve growth factor concentration in neonatal mouse brain. Life Sci 1981; 28: 1777–87
David S, Nathaniel EJH. Neural changes induced by neonatal hypothyroidism: an ultrasound study. Am J Anat 1983; 167: 381–94
Dussault JH, Ruel J. Thyroid hormones and brain development. Ann Rev Physiol 1987; 49: 321–4
Patel AJ, Rabie A, Lewis PD, et al. Effect of thyroid deficiency on postnatal cell formation in the rat brain: a biochemical investigation. Brain Res 1976; 104: 3–38
MacKay-Sim A, Beard MD. Hypothyroidism disrupts neural development in the olfactory epithelium of adult mice. Dev Brain Res 1987; 36: 190–8
Henkin RI, Shatzman AR. TSH, T3 and T4 stimulate adenylate cyclase in purified taste bud membranes. Clin Res 1981; 29: 580A
Law J, Henkin RI. Thyroid hormone inhibits taste bud membrane (TBM) adenosine 3′5′ monophosphate (cAMP) phos-phodiesterase (PDE) activity: a possible mechanism for hypogeusia in hypothyroidism. Clin Res 1983; 31: 528a
Law J, Henkin RI. Taste bud adenosine-3′5′-monophosphate phosphodiesterase: activity, subcellular distribution and kinetic parameters. Res Comm Chem Path Pharm 1982; 38: 439–52
Napolitano G, Palka G, Lio S, et al. Is zinc deficiency a cause of subclinical hypothyroidism in Down syndrome? Ann Genet 1990; 33: 9–15
Dai WL, Henkin RI. Hypothroidism induces zinc deficiency in humans. Clin Res 1994; 42: 172A
Arthur JR, Nicol F, Beckett JR. Hepatic iodothyronine 5′-deiodinase: the role of selenium. Biochem J 1990; 272: 537–40
Behne D, Kyriakopoulos A, Meinhold H, et al. Identification of type 1 iodothyronine 5’ deiodinase as a selenoenzyne. Biochem Biophys Res Comm 1990; 173: 1143–9
Berry MJ, Bann L, Larsen PR. Type 1 iodothyronine deiodinase is a selenocystein-containing enzyme. Nature 1991; 349: 438–40
Chandhury S, Sarkar PK. Stimulation of tubulin synthesis by thyroid hormones in the developing rat brain. Biochim Biophys Acta 1983; 763: 93–8
Valcana T, Einstein ER, Csejtey J, et al. Influence of thyroid hormones on myelin proteins in the developing rat brain. J Neurol Sci 1975; 25: 19–27
Noguchi T, Sugiasaki T. Hypomyelation in the cerebrum of the congenitally hypothyroid mouse (hyt). J Neurochem 1984; 42: 891–3
Nicholson JL, Altman J. Synaptogenesis in the rat cerebellum: effects of early hypo- and hyperthyroidism. Science 1972; 176: 530–1
Gottesfeld Z, Garcia CJ, Chronister RB. Perinatal, not adult, hypothyroidism suppresses dopaminergic axon sprouting in the deafferented olfactory tubercle of adult rats. J Neurosci Res 1987; 18: 568–73
Johanson IB. Development of olfactory and thermal responsiveness in hypothyroid and hyperthyroid rat pups. Dev Psychobiol 1980; 13: 343–52
Dai WL, Varma VM, Henkin RI. Distribution and uptake of radioactive iodine (RAI) and early oral symptoms in patients with thyroid cancer and RAI. Clin Res 1993; 41: 357A
Terry MC, Segal C. The association of diabetes and taste blindness. J Hered 1947; 38: 135–9
Bonatti M. Diabetes e gusto. Arcisp S Anna Ferrara 1950; 3: 245
Fabbi F. Gustatory sense modifications in diabetes. Arch Ohren Nasen Kehl Heilk 1954; 164: 543–6
Jorgensen MB, Buch NH. Studies on the sense of smell and taste in diabetics. Acta Otorhinolaryngol 1961; 53: 539–45
Law JS, Henkin RI. Low parotid saliva calmodulin in patients with taste and smell dysfunction. Biochem Med Metab Biol 1986; 36: 118–24
Chang FH, Bourne HR. Dexamethasone increases adenyl cyclase activity and expression of the α-subunit of Gs in GH3 cells. Endocrinology 1987; 121: 1711–5
Pieroni JB, Jacobowitz O, Chen J, et al. Signal recognition and integration of adenylate cyclase via inhibitory GTP-binding proteins. J Biol Chem 1990; 262: 11897–900
Saito N, Guitant X, Hayward M, et al. Corticosterone differentially regulates expression of Gsα and Giα messenger RNA and protein in rat cerebral cortex. Proc Natl Acad Sci USA 1989; 86: 3906–10
Gannon MN, Akompong T, Billingsley ML, et al. Adrenalec-tomyinduced alterations in calmodulin-dependent hippocampal adenylate cyclase activity: role of guanine nucleotide-binding proteins. Endocrinology 1994; 134: 853–7
Vitamin D. Ergocalciferol. Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2178
Jones PB, McCloskey EV, Kanis JA. Transient taste-loss during treatment with etidronate. Lancet 1987; 2: 637
Etidronate (Didronel). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1808
Etretinate (Tegison). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1908
Hesse E, Schnuch A. Taste and olfactory disturbances after treatment for acne with isotretinoin, a 13-cis-isomer of retinoic acid. Eur Arch Otorhinolaryng 1991; 247: 382–3
Whittet HB, Shinkwin C, Freeland AP. Anosmia due to nasal administration of corticosteroid. BMJ 1991; 303: 651
Terfenadine (Seldane). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1321
Loratadine (Claritin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2131
Promethazine (Phenergan). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2582
Oxymetazoline (Afrin) American Hospital Formulary. Bethesda: American Society of Pharmacists, 1994: 1845
Phenylephrine/Neosynephrine (4-way fast acting nasal spray). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994:683
Pseudoephedrine (in Seldane discussion). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1326
Butorphanol (Stadol). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1381–4
Von Anrep F. Uber die physiologische Wirkurng des kokains. Pflugers Arch 1879; 21: 38–77
Knapp H. Hydrochlorate of cocaine-experiments and application. Med Rec 1884; 26: 461–3
Kiesone F. Uber die Wirkung des Cocain und der Gymnemasauve auf die Schleinnaut der Zunge und des Mandraums. Philosoph Stud Wundt 1894; 9: 510–27
Zilstorff-Pederson K. Sense of smell alterations by cocaine and tetracaine. Arch Otolaryngol 1965; 82: 53–5
Zilstorff K, Herbild O. Parosmia. Acta Otolaryngol Suppl 1979; 360: 40–1
Gordon AS. The effect of chronic cocaine abuse on human olfaction. Arch Otol Head Neck Surg 1990; 116: 1415–8
Macht DI, Macht MB. Comparison of effect of cobra venom and opiates on olfactory sense. Am J Physiol 1940; 129: P411–2
Rebattie JP, Lafon H, Caigfinger H. La pathologie iatrogene en oto-rhinolarngologie. J Fr Otol Rhino Laryngol 1972; 21: 931–5
Bertino M, Beauchamp GK, Engelman K. Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am J Physiol 1991; 26: R59–63
Alprozolam (Xanax). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2456
Westhofen M. Drug induced disorders of smell [in German]. Med Montaschr Pharm 1990; 13: 138–40
Amoxapine (Ascendin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1153
Estazolam (Prosom). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 451
Flurazepam (Dalmane). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1959
Oxazepam (Serax). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2605
Triazolam (Halcion). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2422
Ethchlorvynol (Placidyl). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 449
Zolpidem (Ambien). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2189–92
Amytriptyline (Elavil). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2332
Clomipramine (Anafranil). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 578
Desipramine (Norpramin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1313
Imipramine (Tofranil). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 995
Trimipramine (Surmontil). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2608
Bupropion (Wellbutrin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 762
Chlormezanone (Trancopal). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2122
Paroxetine (Paxil). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2267
Setraline (Zoloft). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2000
Venlafaxine (Effexor). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: Suppl. A48–52
Trazodone (Desyrel). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 514
Fluphenazine (Prolixin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 520
Risperidone (Rispendal). Physicans Desk Reference. 48th ed. Montvale: Medical Economics, 1994: A24–A28
Fischer R, Griffin R, Rockey MA. Gustatory chemoreception in man: multidisciplinary aspects and perspectives. Perspect Biol Med 1966; 9: 549–77
Duffield JW. Side effects of lithium carbonate. BMJ 1973; 1: 491
Bressier B. An unusual side-effect of lithium. Psychosomatics 1980; 21: 688–9
Rogers GA. Flavor altered by lithium. Am J Psychiatr 1981; 138:261
Lithium (Eskalith). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2257
Greenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorders. N Engl J Med 1989; 321: 1489–93
Gallizia G, Diversi G. Psychopharmaka und Geschmach. Monatschr Ohrenhlk Laryngol Rhinol 1968; 102: 230–1
Fieve RR. Moodswing. The third revolution in psychiatry. New York: Bantam Books, 1975: 203
Juergens SM. Problems with benzodiazepines in elderly patients. Mayo Clin Proc 1993; 68: 818–820
Cartlidge NE, Hudgson P, Weightman D. A comparison of baclofen and diazepam in the treatment of spasticity. J Neurol Soc 1974; 23: 17–24
Lingjaerrde O. Benzodiazepines in the treatment of schizophrenia: an updated survey. Acta Psychiatr Scand 1991; 84:453–9
Fischer R, Griffin F, Archer AC, et al. Weber ratio in gustatory chemoreception: an indication of systemic (drug) reactivity. Nature 1965; 207: 1049–53
Barondes SH. Thinking about prozac. Science 1994; 263: 1102–3
Baclofen (Lioresal). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 985
Turner P, Cattell WR, Patterson SS. Bamifylline hydrochloride, a new xanthine derivative in chronic bronchitis. J New Drugs 1966; 5: 333–6
Cyclobenzaprine (Flexaril). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1455
Dantrolene (Dantrium). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1806
Methocarbamol (Robaxin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1899
Sulindac (Clinoril). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1415
Amphetamine/Dextroamphetamine (Obetrol). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1843
Fenfluramine (Pondimin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1894
Mazindol (Sanorex). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2078
Phendimetrazine (Bontril). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 778
Ahokas AJ, Payne JG, Goetzi FR. The influence of amphetamine sulfate upon the acuity of the sense of taste for sucrose and upon the sensation complex of appetite and satiety. Perm Fnd Med Bull 1950: 107–12
Herxheimer A. Amphetamine and taste in man. In: Herxheiner A, editor. Symposium on drugs and sensory functions. Boston: Little, Brown and Co., 1968: 131–9
Mata F. Effect of dextroamphetamine on bitter taste threshold. J Neuropsych 1963; 4: 315–20
Guild AA. Olfactory acuity in normal and obese human subjects: diurnal variations and the effect of D-amphetamine sulfate. J Laryngol 1956; 70: 408–14
Turner P. Amphetamines and smell threshold in man. In: Herxheiner A, editor. Drugs and sensory functions. London: Churchill, 1968
Goetzl FR, Stone F. The influence of amphetamine sulfate upon olfactory acuity and appetite. Gastroenterology 1948; 10: 708–13
Phentermine (Fastin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2258
Calne DB, Williams AC, Neophytides A, et al. Long term treatment of Parkinsonism with bromocryptine. Lancet 1978; 1: 735–8
Mania-Farnell BL, Farbman AI, Bruch RC. Bromocryptime, a dopamine D2 receptor agonist, inhibits adenylyl cyclase activity in rat olfactory epithelium. Neuroscience 1993; 57: 173–80
A second report on levodopa. Med Lett 1969; 11:1
Barbeau A. L-Dopa therapy: past, present and future. Ariz Med 1970; 27: 1–6
Walzholz U, Schoenfelder H. Fortschritte in der Behandlung der Parkinson-syndrome mit L-dopa durch Kombination mit einem decarboxylase-henne Ergebnisse: einem Langzeitstudie. Nervanartz 1972; 43: 531–2
Ziegfried J, Zumstein H. Changes in taste under L-Dopa therapy. Z Neurol 1971; 200: 345–8
L-dopa (Larodopa). Nutley: Roche Laboratories, 1938
Haga M, Tomita H. Zinc chelation capacity of drugs causing taste disturbance [in Japanese]. Micrometal Metab 1979; 7: 41–52
Neundorfor B, Valdivieso T. Parosmie und aromatische anosmie unter L-Dopa Therapie. Nervenartz 1977; 48: 283–4
Pergolide (Perman). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 572
Trihexyphenidyl (Artane). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1153
Blom S. Trigeminal neuralgia: its treatment with a new anticon-vulsant drug. Lancet 1962; 1: 839–40
Nagao M, Furakawa T, Nagasawa T. Clinical results with Tegretol on trigeminal neuralgia. Prospect Dent Field 1967; 29: 1258–64
Barajas Garcia-Talavera F. Ageusia in a patient treated with carbamazepine. Neurologia 1988; 31: 126–7
Halbreich U. Tegretol dependency and diversion of the sense of taste. Isr Ann Psychiatr 1974; 12: 325–32
Ono T, Ishii Y, Ushio M. et al. Clinical results on 5-carbonyl-dibenzozepin (Tegretol) on trigeminal neuralgia. Dent Outlook 1962; 25: 155
Carbamazapine (Tegretol). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 585
Felbamate (Felbatol). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2473–6
Turner P. Some observations on centrally-acting drugs in man. Proc R Soc Med 1965; 58: 913–4
Takeda M, Kitao K. Effect of monoamines on the taste buds in the mouse. Cell Tissue Res 1980; 210: 71–8
Soni NK, Chatterji P. Gustotoxicity of bleomycin. J Otol Rhino Laryngol Relat Spec 1985; 47: 101–4
Bleomycin (Blenoxane). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 653
Rozencweig M, Van Hoff DD, Abele R, et al. Cis-platin. Cancer Chemother 1979; 1: 107–25
Howell SB, editor. Platinum and other metal coordination compounds in cancer chemotherapy. New York: Plenum, 1993
Schiller JH, Rozental J, Tutsch KD, et al. Inadvertent administration of 480 mg/m2 of cisplatin. Am J Med 1989; 86: 624–5
Hoffman DL, Howard Jr JR, Sarma R, et al. Encephalopathy, myelopathy, optic neuropathy and anosmia associated with intravenous cytosine arabinoside. Clin Neuropharmacol 1993; 16: 258–262
Cytarabine (Cytosar-U). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2405
Guthrie S, Way S. Treatment of advanced carcinoma of the cervix with adriamycin and methotrexate combined. Obstet Gynecol 1974; 44: 586–9
Doxorubicin (Adriamycin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 459
Bedikian AY, Valdivieso M, Bodey GP, et al. Phase 1 clinical studies with gallium nitrate. Cancer Treat Rep 1978; 62: 1449–53
Fluorouracil (Efudex). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1907
Interferon alfa 2a, recombinant (Roferon-A). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1947
Interferon alfa 2b (Intron-A). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2147
Interleukin 2 (Proleukin). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 801
Lomustine-CCNU (Cee NU). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 654
Duhra P, Foulds IS. Methotrexate-induced impairment of taste acuity, Clin Exp Dermatol 1988; 13: 126–7
State FA, Hamed MS, Bonok AA. Effect of vincristine on the histological structure of taste buds. Acta Anat (Basel) 1977; 99: 445–9
Vincristine (Oncovin). Physicans Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1253–5
Journey LJ, Geory P, Goldstein MN. Effect of vincristine on the fine structures of hela cells during mitosis. J Natl Cancer Inst 1965; 33: 355–61
Richards JF, Jones RGW, Beer CT. The effect of vinblastine on the nucleic acid metabolism of thymic cell suspensions. Proc Am Assoc Cancer Res 1963; 4: 57–62
Creasey WA, Markiw MF. Biochemical effects of vinca alkaloids. Biochem Biophys Acta 1974; 87: 601–9
Azathioprine (Imuran). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 703
Mulder NH, Smith JM, Kreumer WMI, et al. Effect of chemotherapy on taste sensation in patients with disseminated multiple myeloma. Oncology 1983; 40: 36–8
Reyes ES, Talley RW, O’Bryan RM, et al. Clinical evolution of 1 -3-bis(2-chloroethyl)-1 -nitrosurea (BCNU;NSC-409962) with fluoxymesterone (NSC-12165) in the treatment of solid tumors. Cancer Chemother Rep 1973; 57: 225–30
Rees RB, Bennett JA, Marback HI, et al. Methotrexate and psoriasis. Arch Dermatol 1967; 95: 2–11
Roenigk HH, Fowler-Bergfeld W, Curtis GH. Methotrexate for psoriasis in weekly oral dose. Arch Dermatol 1969; 99: 86–93
Nyffers A. Benefits and adverse drug experiences during longterm methotrexate treatment of 248 psoriatics. Dan Med J 1978; 25: 208–11
Rapuzzi G, Bruschi ML, Ricagno G. Importanza dei nucleosidi citidina et uridina mella funzione dei chemocettori gustavi I, II. Bull Soc Ital Biol Sperimental 1967; 43: 1540–4
Hollstein M, Sidransky D, Vogelstein B, et al. P53 mutation in human cancers. Science 1991; 253: 49–53
Sturzbacher HW, Maimets T, Chumakov P. P53 interacts with P34 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene 1990; 5: 795–801
DeWys WD, Walters K. Abnormalities of taste sensation in cancer patients. Cancer 1975; 36: 1888–96
Bartoshuk LM. Chemosensory alterations and cancer therapies. NCI Monogr 1990;9: 179–94
Kalmus H, Farnsworth D. Impairment and recovery of taste following irradiation of the oropharynx. J Laryngol Otol 1959; 73: 180–2
MacCarthy-Levinthal EM. Post radiation mouth blindness. Lancet 1959; 2: 1138–9
Conger AD. Loss and recovery of taste acuity in patients irradiated to the oral cavity. Radiat Res 1973; 53: 338–47
Mossman KL, Henkin RI. Radiation induced changes in taste acuity in cancer patients. Int J Radiat Oncol Biol Phys 1978; 4: 663–70
Mossman KL, Chencharick JD, Scheer AC, et al. Radiation-induced changes in gustatory function. Int J Radiat Oncol Biol Phys 1979; 5: 521–8
Sato K. Quantitative examination of taste deficiency due to radiation therapy. Radiat Med 1984; 2: 61–70
Uphir D. Changes in smell acuity induced by radiation exposure of the olfactory mucosa. Arch Otolaryngol Head Neck Surg 1988; 114: 853–5
Carmichael KA, Jennings AS, Doty RL. Reversible anosmia after pituitary irradiation. Ann Intern Med 1984; 100: 532–3
Mossman KL, Martini AJ, Henkin RL Radiation-induced changes in sodium preference and fluid intake in the rat. Int J Radiat Oncol Biol Phys 1979; 36: 191–6
Henkin RI. Prevention and treatment of hypogeusia due to head and neck irradiation. JAMA 1972; 220: 870–1
Bolze MS, Fosmire GJ, Stryker JA, et al. Taste acuity, plasma zinc levels and weight loss during radiotherapy: a study of relationships. Radiology 1982; 144: 163–9
Silverman JE. Zinc supplementation and taste in head an neck cancer patients undergoing radiation therapy. J Oral Med 1983; 38: 141–61
Metoclopramide (Reglan). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1896
Granisetron (Kytril). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 324–5
Famotidine (Pepcid). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1510
Sucralfate (Carafate). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1293
Serby M, Flicker C, Rypma G, et al. Scopolamine and olfactory function. Biol Psychiat 1989; 28: 79–82
Scopolamine (Donnatal). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 1886
Sumatriptan (Imitrex). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 792
Nicotine. (Nicoderm, patch). Physicians Desk reference. 48th ed. Montvale: Medical Economics, 1994: 1308–10
Disulfiram (Antabuse). Physicians Desk Reference. 48th ed. Montvale: Medical Economics, 1994: 2511
Skoudy AP, Zilstorff-Pederson K. The influences of acetyl-cho-line-like substances, menthol and strychnine on olfactory receptors in man. Acta Physiol Scand 1954; 32: 252–8
Furcheimer I. Geruchs- und Geschmacksempfindungen nach introvenosen Injektionen von Salversan. Dermat Centralbld 1916; 19: 98–101
Kraupa-Runk M. Perverse Geruchs- und Geschmacksemfind-ungen nach Neosalversan Injektionen. Munch Med Wochschr 1916; 63: 46
Simons PWGP. Arsenic medication. Pharm Wkbld 1927; 74: 315–21
Albert A. Selective Toxicity. 7th ed. New York: Chapman and Hall, 1985: 206–65
Moyer TP. Testing for arsenic. Mayo Clin Proc 1993; 68: 1210–1
Seeber H. Nasal mucosal injuries and olfactory disorders caused by occupational exposure to chromium dust [in German; abstract in English]. Z Gesamte Hyg 1980; 26: 506–8
Seeber H. Taste disorders in chromium exposed workers [in German; abstract in English]. Z Gesamte Hyg 1990; 36: 33–4
Rossberg G, Schaupp H, Schmidt W. Gerucks- und Geschmackswermozen bei Arbeitern den chemischen und Metallver arbeitendem Industrie. Z Laryngol Rhinol 1966; 45: 571–90
Faleg G, Lenzi R, Marzi F. Le alterzoni dell’ olfatto nell’ intossicazione cronica professi male da mercurio. Folin Med (Napoli) 1959; 42: 1487–93
Shimada I. Two receptor sites in the labellar sugar receptor of the fleshfly. J Insect Pathol 1973; 21: 1675–80
Hara TJ, Law YMC, MacDonald S. Effects of mercury and copper on the olfactory response in rainbow trout, Salmo gairdneri. J Fish Res Board Can 1977; 33: 1568–73
Detheir VG. The physiology and histology of the contact che-moreceptor of the blowfly. Q Rev Biol 1955; 30: 348–71
Louria DC, Joselow MM, Browder AA. The human toxicity of certain trace elements. Ann Intern Med 1972; 76: 207–319
Chisholm Jr JJ, Kaplan E. Lead poisoning in childhood-comprehensive management and prevention. J Pediatr 1968; 73: 942–50
Nilson R. Aspects on the toxicity of cadmium and its compounds. Proceedings of the National Science and Ecological Research Council Stockholm 1970; 7: 19
Hastings L. Sensory neurotoxicology: use of the olfactory system in the assessment of toxicity. Neurotoxicol Teratol 1990; 121: 455–8
Takagi SF, Iino M, Yarita H, et al. Ionic stimulation of the olfactory epithelium in the bullfrog and the carp. Jpn J Physiol 1978; 28: 129–48
Rose CS. Olfactory impairment after occupational cadmium exposure. J Occup Med 1992; 34: 600–5
Yar’eva GY. The role of reactive groups in protein complexes in taste receptor stimulation. Biophys 1957; 2: 653–6
Pyatayev GT. State of the olfactory function in zinc production workers. Zn Ushn Nos Gorlov Bolezn 1971; 31: 17–21
Hunnicutt LG. The effect of zinc sulfate on the olfactory mucous membrane in dogs and monkeys. Trans Pacific Coast Oto Othalmol Soc 1939; 24: 72–80
Harding JW, Getchell TV, Margolis FL. Denervation of the primary olfactory pathway in mice V. Long-term effect of intranasal ZnSO4 irrigation on behavior, biochemistry and morphology. Brain Res 1978; 140: 271–85
McCurdy PR. Parenteral iron therapy. II. A new iron-sorbitol citric acid complex for intramuscular injection. Ann Int Med 1964; 61: 1053–64
Amoore JE. Effects of chemical exposure on olfaction in humans. In: Barrows CS, editor. Toxicology of the nasal passages. Washington DC: Hemisphere Publishing Co, 1986: 155–90
Schiffman SS, Nagle HT. Effects of environmental pollutants on taste and smell. Otolaryngol Hd Nk Surg 1992; 106: 693–700
Schiffman SS, Gatlin CA. Clinical physiology of taste and smell. Ann Rev Nutr 1993; 13: 405–36
Herberhold C. Funktionsprufungen und Störungen der Geruchsinnes. Arch Otorhinolaryngol 1975; 210: 67–164
Ryan CM. Cacosmia and neurobehavioral dysfunction as-ociated with occupational exposure to mixtures of organic solvents. Am J Psychiat 1988; 145: 1442–5
Laciak J, Sipa K. The importance of the sense of smelling in workers of some branches of the chemical industry [in Polish]. Med Pr 1958; 9: 85–90
Emmett EA. Parosmia and hyposmia induced by solvent exposure. Brit J Ind Med 1976; 33: 196–9
Schwartz BS, Ford P, Bolla KI, et al. Solvent-associated decrements in olfactory function in paint manufacturing workers. Am J Ind Med 1990; 18: 697–706
Sandmark B, Brown I, Lofgren L, et al. Olfactory function in painters exposed to organic solvents. Scand J Work Envior Health 1989; 15: 60–3
McNulty MJ, Cassnova-Schmitz M, Heck HD. Metabolism of dimethylamine in the nasal mucosa of the Fisher 344 rat. Drug Metab Dispos 1983; 11: 421–5
Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res 1983; 42: 4875–917
Shultz WH. The reaction of the respiratory mechanism to chlorine. J Pharm Exp Ther 1918; 11: 180–1
Jiang XZ, Buchler LA, Morgan KT. Pathology of toxic responses to the RD50 concentratiom of chlorine gas in the nasal passages of rats and mice. Toxicol Appl Pharmacol 1983; 71: 225–36
Bardodej Z, Vyskocil J The problem of trichloroethylene in occupational medicine. Arch Ind Health 1966; 13: 581–2
von Oettingen WF. The halogenated hydrocarbons of industrial and toxicological importance. Amsterdam: Elsevier Publishing Co., 1964:259
Huff JE. New evidence on the old problems of trichloroethylene. Ind Med Surg 1971; 40: 25–32
Naus A, Pihrt J Disorders of smell caused by prolonged action of trichloroethylene vapors on the olfactory analyzer [in Czech]. Proc Lek 1960; 12: 14–7
Vyskocil J Effect of work with trichloroethylene upon the central nervous system. Lek Listy 1953; 8: 269–71
Buxton PH, Hayward M. Polyneuritis cranialis associated with industrial trichloroethylene poisoning. J Neurol Neurosurg Psychiat 1967; 30: 511–8
Salvini M, Binaschi S, Riva M. Evaluation of the psychophysical functions in humans exposed to trichloroethylene. Br J Ind Med 1971; 28: 293–5
Barrett L, Garrel S, Arsoc P, et al. Interet de l’etude des potentials evoques du trijumeau dans l’intoxication chronique au trichloroethylene: Resultats preliminaires. Toxicol Eur Res 1982; 4: 159–62
Ahlmark A, Forssman S. Effect of trichloroethylene on the organism. Acta Physiol Scand 1951; 22: 326–39
Bardodej Z, Berka I, Chalupa B, et al. Recent advances in our knowledge of the effects of trichloroethylene upon the health of workers. Prac Lek 1952; 4: 441–67
Friberg L, Kylin B, Nystrom A. Toxicities of trichloroethylene and tetrachlorethylene and Fujiwara’s pyridine-alkali reaction. Acta Pharmacol Toxicol 1953; 9: 303–12
McBirney RS. Trichloroethylene and dichloroethylene poisoning. Arch Ind Hyg Occup Med 1954; 10: 130–3
Kleinfeld M, Tabershaw IR. Trichloroethylene toxicity. Arch Ind Hyg Occup Med 1954; 10: 134–41
Hurtt H. Histopathology of acute toxic responses in selected tissues from rats exposed by inhalation to methyl bromide. Fundam Appl Toxicol 1987; 9: 352–65
Prah JD. Decrements in olfactory sensitivity due to ozone exposure. Percept Mot Skills 1979; 48: 317–8
Schwartz BS, Doty RL, Monroe CB, et al. Olfactory function in chemical workers exposed to acrylate and methacrylate vapors. Am J Publ Health 1989; 79: 613–8
Lenhardt E, Rollin H. Berufsbedingte Riechstörungen. HNO 1969; 17: 104–6
Chang JCF, Gross EA, Swenberg JA, et al. Nasal cavity deposition, histopathology and cell proliferation after single or repeated formaldehyde exposures in B6C3F1 mice and F-344 rats. Toxicol Appl Pharmacol 1983; 68: 161–76
Casanova-Schmitz M, David RM, Heck HD’A. Oxidation of formaldehyde and acetaldehyde by NAD+ -dependent dehy-drogenases in rat nasal mucosal homogenates. Biochem Pharmacol 1984; 33: 1137–42
Bucher JR, Boorman GA, Gupta BN, et al. Two hour methyl isocyanate exposure and 91- day recovery: a preliminary description of pathological changes in F344 rats. Environ Health Perspect 1987; 72: 71–75
Nathanson G. Acute CO poisoning: pathological changes of olfactory organ. Acta Otolaryngol 1929; 13: 409
Mergler D, Beauvois B. Olfactory threshold shift following controlled 7-hour exposure to toluene and/or xylene. Neurotoxicology 1992; 13: 211–5
Harada N, Fujii M, Dode H. Olfactory disorders in chemical plant workers exposed to SO2 and/or NH2. Jpn J Ind Health 1983; 59: 17–23
Ahlborg G. Hydrogen sulfide poisoning in shale oil industry. Arch Ind Hyg 1951; 3: 247–66
Glass DC. A review of the health effects of hydrogen sulphide exposure. Ann Occup Hyg 1990; 34: 323
Naus A. Alterations of the smell acuity caused by menthol. J Laryng 1968; 82: 1009–11
Naus A. Olphatic Properties of Industrial Matters. Prague: Charles University, 1976: 55–65
Kmita S. The influence of benzene (sic) vapors on the upper respiratory tract and on the organ of smell [in Polish]. Med Pr 1953; 4: 119–30
Popivanova P. Modification in gustatory and olfactory sensitivity in workers exposed to the effect of chemical agents. Acta Otol Rhinol Laryngol Belg 1980; 34: 556–61
Hotz P. Smell or taste disturbances, neurological symptoms and hydrocarbon exposure. Int Arch Occup Environ Health 1992; 63: 525–30
Spealman CR. Odors, odorants and deodorants in aviation. Ann NY Acad Med 1934; 58: 40–3
Koelsch F. Handbuch des Burufkrankheiten. 2nd ed. Jena: Gustav Fischer Verlag, 1959
Tagashira N, Harada Y. Olfaction and gustation in poisonous gas workers. In: Tomita H, editor. Japanese Symposium on Taste and Smell 14. Tokyo: Nihon University School of Medicine, 1980:77–80
Hill L. An address on gas poisoning read before the Medical Society of London. BMJ 1915; 2: 801–4
Morgan KT, Patterson DL, Gross EA. Response of the nasal mucociliary apparatus to airborne irritants. In: Barrow CS, editor. Toxicology of the nasal passages. New York: Hemisphere Publishing Co., 1986: 123–41
Cralley LV. The effect of irritant gases upon the rate of ciliary activity. J Ind Hyg Toxical 1942; 24: 193–8
Lambert RA. Experimental pathology of war gases, exclusive of mustard gas. In: Weed FW, MacAfee L, editors. The Medical Department of the US Army in the World War. Vol 14. Medical Aspects of gas warfare. Washington DC: US Government Print Office, 1926: 421–511
Smith RG, Battigelli MC, Cook RR, et al. Chlorine and hydrogen chloride. Washington DC: National Academy of Science (USA), 1976: 108
Ailing CC. Dysesthesia of the lingual and inferior aveolar nerves following third molar surgery. J Oral Maxillofac Surg 1986; 44: 454–7
Bruce RA, Fredrickson GC, Small GS. Age of patients and morbidity associated with mandibular third molar surgery. J Am Dent Assoc 1980; 101: 240–5
Goldberg MH, Nemarich AN, Marco II WP. Complications after mandibular third molar surgery: a statistical analysis of 500 consecutive procedures in private practice. J Am Dent Assoc 1985; 111: 277–9
Osborn TP, Fredrickson Jr G, Small IA, et al. A prospective study of complications related to mandibular third molar surgery. J Oral Maxillofac Surg 1985; 43: 767–9
Kipp DP, Goldstein BH, Weiss WW. Dysesthesia after mandibular third molar surgery: a retrospective study and analysis of 1377 surgical procedures. J Am Dent Assoc 1980; 100: 185–92
Van Gool AV, ten Bosch JJ, Boering G. Clinical consequences of complaints and complications after removal of the mandibular third molar. Int J Oral Surg 1977; 6: 29–37
Schwartz LJ. Lingual anesthesia following mandibular odontectomy. J Oral Surg 1973; 31: 918–20
Gregg JM. Surgical management of lingual nerve injuries. Oral Maxillofac Surg Clin North Am 1992; 4: 417–24
La Banc JP, Gregg JM. Trigeminal nerve injuries. Oral Maxillof. Surg Clin North Am 1992; 4: 277–83
Nickel, Jr AA. A retrospective study of paresthesia of the dental alveolar nerves. Anesth Prog 1990; 37: 42–5
Nickel Jr AA. Regional anesthesia. Oral Maxillofac. Surg Clin North Am 1993; 5: 17–24
Ragsdale DS, McPhee JC, Scheur T, et al. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science 1994; 265: 1724–6
Lum CKL, Henkin RI. Sugar binding to purified fractions from bovine taste buds and epithelial tissue: relationships to bioactivity. Biochim Biophys Acta 1976; 421: 380–94
Beidier JL, Beidier LM, Henkin RI. On the molecular defect in gustin in patients with hypogeusia. Clin Res 1991; 39: 234A
Fredholm BB, Persson CGA. Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol 1983; 81: 673–6
Santoyo H, Corona R, Sotello J. Total recovery of visual function after treatment for cerebral cystechcosis. N Engl J Med 1991; 324: 1137–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henkin, R.I. Drug-Induced Taste and Smell Disorders. Drug-Safety 11, 318–377 (1994). https://doi.org/10.2165/00002018-199411050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199411050-00004